Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on July 29th, 2023%
Global venture funding for digital health start-ups remains mired at low levels, as the number of investment deals in the second quarter of 2023 dropped to its lowest level in eight years. . . . → Read More: Infographic – Digital Health Venture Funds Remain Stuck
By Alan, on July 21st, 2023%
A biotechnology company designing immunotherapies for solid tumor cancers with a patient’s white blood cells is raising $80 million in its initial public offering or IPO. . . . → Read More: Cancer Immunotherapy Biotech Issues $80M IPO
By Alan, on July 15th, 2023%
Investments in life science start-ups in the U.S. show continued declines into the second quarter of 2023, reaching levels not seen in four or five years. . . . → Read More: Infographic – U.S. Life Science Venture Activity Keeps Falling
By Alan, on July 13th, 2023%
A new venture fund says it’s investing in health and life science start-ups implementing advanced technologies, particularly artificial intelligence, that promise to transform the field. . . . → Read More: Venture Fund to Back Life Science A.I. Start-Ups
By Alan, on July 8th, 2023%
Venture capital funding for start-ups worldwide continued dropping in the second quarter of 2023 with dollar volumes down by double digits from just the first quarter of the year. . . . → Read More: Infographic – Venture Funds Continue Slide in Q2
By Alan, on July 3rd, 2023%
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round. . . . → Read More: Synthetic DNA Company Gains $10M in Venture Round
By Alan, on June 23rd, 2023%
A company creating a network of long-range high-altitude balloons to expand the scope of global weather forecasting is raising $6 million in seed funds. . . . → Read More: Weather Balloon Data Company Raises $6M in Seed Funds
By Alan, on June 19th, 2023%
A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder. . . . → Read More: Biotech Start-Up to Discover Cystic Fibrosis Therapy
By Alan, on June 14th, 2023%
A company detecting early-stage crop diseases with handheld devices and artificial intelligence is raising $3.5 million in its seed venture round. . . . → Read More: Crop Health Device Company Raises $3.5M in Early Funds
By Alan, on June 7th, 2023%
A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|